* Apyx Medical Corp APYX.OQ reported a quarterly adjusted
loss
of 11 cents per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss of 7
cents per share.
* Revenue rose 31.8% to $13.57 million from a year ago;
analysts
expected $14.33 million.
* Apyx Medical Corp's reported EPS for the quarter was a
loss of 3
cents.
* The mean earnings estimate of analysts had risen by
about 8.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Apyx Medical Corp shares had fallen by 12.9% this
quarter and
gained 87.2% so far this year.
* The company reported a quarterly loss of $994 thousand.
* Wall Street's median 12-month price target for Apyx
Medical Corp
is $9.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 10 at 11:53 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.07 -0.11 Missed
Mar. 31 2023 -0.13 -0.10 Beat
Dec. 31 2022 -0.14 -0.17 Missed
Sep. 30 2022 -0.14 -0.17 Missed